Researchers wanted to determine if they could safely reduce an 8-week course of conformal radiotherapy and achieve similar efficacy into a 4-week course in men with an intermediate prostate cancer risk . They determined that this shorter (with high dose) regimen was not inferior to conventional radiotherapy and that it did not increase either acute or late toxicities.
meetinglibrary.asco.org/con...
Joel
What is the role of androgen deprivation and prostate cancer treatment?
Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies
Newly Diagnosed 
